Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Xspray Pharma - Filing #690673

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—		—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	453 200 SEK	—	—	—	—	—	340 838 SEK	—	—	—	—	—
Current assets	132 229 SEK	—	—	—	—	—	282 065 SEK	—	—	—	—	—
Non-current liabilities	560,000 SEK	—	—	—	—	—	1 185 SEK	—	—	—	—	—
Current liabilities	28 851 SEK	—	—	—	—	—	29 966 SEK	—	—	—	—	—
Revenue	—	—	—	– SEK	—	—	—	—	—	—	– SEK	—
Profit (loss)	—	– SEK	– SEK	131 670 SEK	131 670 SEK	– SEK	—	– SEK	– SEK	– SEK	96 698 SEK	96 698 SEK
Other comprehensive income	—	– SEK	– SEK	– SEK	– SEK	– SEK	—	– SEK	– SEK	– SEK	– SEK	– SEK
Comprehensive income	—	– SEK	– SEK	131 670 SEK	131 670 SEK	– SEK	—	– SEK	– SEK	– SEK	96 698 SEK	96 698 SEK